20 sources
Who is covering this
FDA adds rare vision-loss warning to popular GLP-1 drugs
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands. The Food and Drug Administration is adding a new warning about possible...
CBS News What to know about new GLP-1 warning on possible vision loss
Dr. Jon LaPook joins "CBS Mornings" to break down the facts on a new warning about GLP-1 medications causing possible vision loss.
Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Paramount Global
NBC News FDA Orders Warning Label on GLP-1s for Risk of Eye Condition
The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare eye condition that may cause permanent vision loss.
Lean: Leans left VideoFactuality: HighCountry: United StatesFunding: CorporateOwner: Comcast
NDTV GLP-1 Drugs Receive New Warning Labels Over Rare Blindness Risk
The order applies to all GLP-1s.
Lean: Center Fact-focusedFactuality: HighCountry: IndiaFunding: CorporateOwner: RRPR HoldingCNBC FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
Lean: Center Fact-focusedFactuality: HighCountry: United StatesFunding: Corporate


















